Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

26.05.2025

2 Acta Neuropathol
1 Alzheimer Dis Assoc Disord
22 Alzheimers Dement
1 Am J Geriatr Psychiatry
3 Biol Psychiatry
2 Brain Res
1 Curr Alzheimer Res
1 Exp Gerontol
13 J Alzheimers Dis
2 J Am Geriatr Soc
1 Lancet
2 Neurobiol Dis
1 Neuropsychology
3 PLoS One
3 Proc Natl Acad Sci U S A


    Acta Neuropathol

  1. FARRELL C, Buhidma Y, Mumford P, Heywood WE, et al
    Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease.
    Acta Neuropathol. 2025;149:49.
    >> Share

  2. BRAAK H, Mayer B, Feldengut S, Schon M, et al
    Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits.
    Acta Neuropathol. 2025;149:50.
    >> Share


    Alzheimer Dis Assoc Disord

  3. CAYIR S, Sadabad FE, Mecca AP, Matuskey D, et al
    Cerebrospinal Fluid Biomarkers and Cognition in Alzheimer Disease and Frontotemporal Dementia in a Memory Clinic Setting.
    Alzheimer Dis Assoc Disord. 2025;39:22-27.
    >> Share


    Alzheimers Dement

  4. WYMAN-CHICK KA, Ferman TJ, Armstrong MJ, Chrenka EAB, et al
    Sex differences in prodromal dementia with Lewy bodies using the National Alzheimer's Coordinating Center data.
    Alzheimers Dement. 2025;21:e70275.
    >> Share

  5. LIU DX, Braskie MN, Cavailles C, Peltz C, et al
    Sleep macro-architecture, nocturnal hypoxemia, and Alzheimer's disease-related MRI patterns among diverse older adults.
    Alzheimers Dement. 2025;21:e70280.
    >> Share

  6. PRYNN JE, Walsh S
    Reply to: Investing in equitable healthy aging: Why Africa must reform social pension schemes to improve Alzheimer's disease and dementia outcomes.
    Alzheimers Dement. 2025;21:e70298.
    >> Share

  7. SALLOWAY S, Pain A, Lee E, Papka M, et al
    TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70293.
    >> Share

  8. XU X, Yang X, Zhang J, Wang Y, et al
    Choroid plexus free-water correlates with glymphatic function in Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70239.
    >> Share

  9. TOROK J, Mezias C, Raj A
    Directionality bias underpins divergent spatiotemporal progression of Alzheimer-related tauopathy in mouse models.
    Alzheimers Dement. 2025;21:e70092.
    >> Share

  10. DOS REIS RG, Singulani MP, Forlenza OV, Gattaz WF, et al
    Kynurenine pathway metabolite alterations in Down syndrome and Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70197.
    >> Share

  11. SHARON O, Zhelezniakov V, Gat Y, Falach R, et al
    Slow wave synchrony during NREM sleep tracks cognitive impairment in prodromal Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70247.
    >> Share

  12. TIAN X, Zhu M, Ma Y, Wang N, et al
    Physical and biopsychosocial frailty, cognitive phenotypes, and plasma biomarkers for Alzheimer's disease in Chinese older adults: A population-based study.
    Alzheimers Dement. 2025;21:e70303.
    >> Share

  13. ASHTON NJ, Benedet AL, Molfetta GD, Pola I, et al
    Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay.
    Alzheimers Dement. 2025;21:e14621.
    >> Share

  14. RODDA J, Kuchenbecker LA, Borelli WV, DeMarco ML, et al
    Global multi-specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkers.
    Alzheimers Dement. 2025;21:e70201.
    >> Share

  15. LIN F
    Comment on "Independent associations of high-density lipoprotein cholesterol and triglyceride levels with Alzheimer's disease and related dementias".
    Alzheimers Dement. 2025;21:e70233.
    >> Share

  16. COHEN AD, Villemagne VL
    A brief history of Abeta imaging.
    Alzheimers Dement. 2025;21:e70291.
    >> Share

  17. ZUELSDORFF M, Abner EL, Balls-Berry JE, Jicha GA, et al
    Introducing social determinants of health to the Alzheimer's Disease Research Center network: Development and implementation in the Uniform Data Set.
    Alzheimers Dement. 2025;21:e70279.
    >> Share

  18. LEUNG YY, Lee WP, Kuzma AB, Nicaretta H, et al
    Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset.
    Alzheimers Dement. 2025;21:e70237.
    >> Share

  19. LI OY, Shin S, Zhou S, Turnbull A, et al
    Relationships between neuropsychiatric symptoms, subtypes of astrocyte activities, and brain pathologies in Alzheimer's disease and Parkinson's disease.
    Alzheimers Dement. 2025;21:e70242.
    >> Share

  20. CUI L, Zhang Z, Huang CC, Yuan CY, et al
    Beyond binary classification: Comparing three region-based multi-phase Abeta staging systems.
    Alzheimers Dement. 2025;21:e70253.
    >> Share

  21. MCHUGH CP, Clement MHS, Phatak M
    AD Workbench: Transforming Alzheimer's research with secure, global, and collaborative data sharing and analysis.
    Alzheimers Dement. 2025;21:e70278.
    >> Share

  22. ZHU X, Xie Y
    Comment on "Glycated hemoglobin and body mass index as mediators of GLP-1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes".
    Alzheimers Dement. 2025;21:e70295.
    >> Share


  23. Correction to "Resistance and resilience to Alzheimer's disease in Down syndrome".
    Alzheimers Dement. 2025;21:e70302.
    >> Share

  24. LIN Y, Shi X, Mu J, Ren H, et al
    Uncovering stage-specific neural and molecular progression in Alzheimer's disease: Implications for early screening.
    Alzheimers Dement. 2025;21:e70182.
    >> Share

  25. BUCHHOLZ S, Kabbani MAA, Bell-Simons M, Kluge L, et al
    The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction.
    Alzheimers Dement. 2025;21:e14403.
    >> Share


    Am J Geriatr Psychiatry

  26. TALMASOV D, Johnson AS, Brown PJ, Provenzano FA, et al
    Depressive Symptoms Correlate With Tau Accumulation Rates in Amyloid Positive Adults.
    Am J Geriatr Psychiatry. 2025;33:756-769.
    >> Share


    Biol Psychiatry

  27. PARK JI, Lee S, Huber B, Devanand DP, et al
    Empirical Classification of Neuropsychiatric Symptoms and Association of Classes With Diagnostic Progression and Cognitive Decline in Mild Cognitive Impairment and Alzheimer's Disease Populations.
    Biol Psychiatry. 2025;97:1059-1066.
    >> Share

  28. WANG Q, Qi S, Jiang R, Sui J, et al
    Unlocking Alzheimer's Disease Heterogeneity: The Role of Normative Modeling, Dynamic Connectivity, and Beyond.
    Biol Psychiatry. 2025;97:1016-1017.
    >> Share

  29. VASILEIADI M, Nestor SM
    From Brain Network Dysfunction to Neuropsychiatric Symptoms in Alzheimer's Disease.
    Biol Psychiatry. 2025;97:1020-1021.
    >> Share


    Brain Res

  30. SALGADO KDCB, Nascimento RGF, Albuquerque ALS, Oliveira LAM, et al
    Melatonin protects mouse hippocampal neurons from neurotoxicity induced by amyloid beta-peptide(25-35).
    Brain Res. 2025;1859:149637.
    >> Share

  31. SOLEIMANI Z, Davoudi S, Saffarzadeh F, Behzadi G, et al
    Restoring neuronal excitability and spatial memory through inhibiting amyloid-beta-induced hyperactive NF-kappaB in a rat model of Alzheimer's disease.
    Brain Res. 2025;1861:149703.
    >> Share


    Curr Alzheimer Res

  32. KARADURAN K, Aydogdu A, Gelisin O, Gunpinar S, et al
    Predictive Value of Complete Blood Count Parameters for Alzheimer's Disease in Relation to Periodontal Status.
    Curr Alzheimer Res. 2025 May 19. doi: 10.2174/0115672050388220250511174043.
    >> Share


    Exp Gerontol

  33. HAKHU S, Hooyman A, Lingo VanGilder J, Schaefer SY, et al
    Association between diffusion MRI-based measures of neurite microstructure and risk of Alzheimer's disease.
    Exp Gerontol. 2025;206:112782.
    >> Share


    J Alzheimers Dis

  34. SACU S, Slattery CF, Friston KJ, Paterson RW, et al
    Neural mechanisms of disease pathology and cognition in young-onset Alzheimer's disease variants.
    J Alzheimers Dis. 2025 May 22:13872877251344325. doi: 10.1177/13872877251344325.
    >> Share

  35. PANDEY JP, Kimball C, Nietert PJ
    Epistatic effects of immunoglobulin KM (kappa marker) allotypes and APOE epsilon4 allele on the risk of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 22:13872877251343315. doi: 10.1177/13872877251343315.
    >> Share

  36. LIU H, Li Y, Sun Z, Xu X, et al
    Altered hemispheres lateralization of brain functional gradients in Alzheimer's disease.
    J Alzheimers Dis. 2025 May 22:13872877251339761. doi: 10.1177/13872877251339761.
    >> Share

  37. COOPER JK
    Differences between East and West may affect dementia studies: Thoughts from the KSA dementia prevalence study.
    J Alzheimers Dis. 2025;105:368-369.
    >> Share

  38. BARTOLINI E, Di Crosta A, La Malva P, Marin A, et al
    Gamma oscillation modulation for cognitive impairment: A systematic review.
    J Alzheimers Dis. 2025;105:331-350.
    >> Share

  39. ZHAI Y, Lu K, Yuan Y, Zhang Z, et al
    Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-kappaB pathway.
    J Alzheimers Dis. 2025;105:416-432.
    >> Share

  40. LABONTE J, Sugarman MA, Pettway E, Zetterberg H, et al
    Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers.
    J Alzheimers Dis. 2025;105:443-452.
    >> Share

  41. NONG Y, Kim JS, Jia L, Arancio O, et al
    The interaction between neurotransmitter receptor activity and amyloid-beta pathology in Alzheimer's disease.
    J Alzheimers Dis. 2025 May 19:13872877251342273. doi: 10.1177/13872877251342273.
    >> Share

  42. LANDRY A, Elsliger S, Gaudet J, Al-Shamaa S, et al
    Psychological impact of biomarker-assisted diagnosis of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 21:13872877251341587. doi: 10.1177/13872877251341587.
    >> Share

  43. MIYASHITA A, Obinata A, Hara N, Mitsumori R, et al
    Association of rare APOE missense variants with Alzheimer's disease in the Japanese population.
    J Alzheimers Dis. 2025 May 21:13872877251340710. doi: 10.1177/13872877251340710.
    >> Share

  44. LI Y, Yao YL, Wu Y
    Causal relationships between plasma proteins and Alzheimer's disease using bidirectional Mendelian randomization.
    J Alzheimers Dis. 2025 May 21:13872877251345151. doi: 10.1177/13872877251345151.
    >> Share

  45. ISHIMARU D, Satake Y, Kanemoto H, Taomoto D, et al
    Thieves in the delusions of theft in patients with Alzheimer's disease living alone: A case series.
    J Alzheimers Dis. 2025 May 21:13872877251343313. doi: 10.1177/13872877251343313.
    >> Share

  46. MENG X, Gong Y, Xiao F, Cao Z, et al
    Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and creative modification techniques.
    J Alzheimers Dis. 2025 May 21:13872877251344188. doi: 10.1177/13872877251344188.
    >> Share


    J Am Geriatr Soc

  47. RYDBERG MG
    A cross-sectional analysis of open payments from pharmaceutical companies to memory center physicians.
    J Am Geriatr Soc. 2025;73:1528-1534.
    >> Share

  48. HARRISON KL, Morgan BE, Friend J, Garrett SB, et al
    "By the Time We Knew ...": Poetic Analysis of End-of-Life Caregiving Experiences for Rapidly Progressive and Slower-Duration Dementia Syndromes.
    J Am Geriatr Soc. 2025;73:1406-1418.
    >> Share


    Lancet

  49. FORTEA J, Boban M, Engelborghs S, Frederiksen KS, et al
    Regulatory asymmetry in Alzheimer's disease care.
    Lancet. 2025 May 14:S0140-6736(25)00907-9. doi: 10.1016/S0140-6736(25)00907.
    >> Share


    Neurobiol Dis

  50. ZARE MS, Abedpoor N, Hajibabaie F, Walker AK, et al
    Gene co-expression patterns shared between chemobrain and neurodegenerative disease models in rodents.
    Neurobiol Dis. 2025;211:106944.
    >> Share

  51. SPENCER B, Schueler A, Sung D, Rissman RA, et al
    Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology.
    Neurobiol Dis. 2025;211:106942.
    >> Share


    Neuropsychology

  52. LOPEZ-MARTOS D, Brugulat-Serrat A, Suarez-Calvet M, Mila-Aloma M, et al
    Robust longitudinal neuropsychological norms in Spanish individuals with nonpathological Alzheimer's disease biomarkers.
    Neuropsychology. 2025 May 22. doi: 10.1037/neu0001013.
    >> Share


    PLoS One

  53. JIANG H, Chen Z, Liu Y, Yang C, et al
    The structure of spontaneous speech changes in Alzheimer's disease: Crosslingual evidence from English and Greek.
    PLoS One. 2025;20:e0324270.
    >> Share

  54. KHEDRAOUI M, Karim EM, Abchir O, Errougui A, et al
    2D-QSAR-guided design of potent carbamate-based inhibitors of acetylcholinesterase.
    PLoS One. 2025;20:e0320789.
    >> Share

  55. HENNEY MA, Hansen BL, Hansen LS, Gronberg MG, et al
    Re-evaluating the choice of gamma stimulation frequency for the potential treatment of Alzheimer's disease: Novel invisible spectral flicker evokes gamma responses at various frequencies.
    PLoS One. 2025;20:e0321633.
    >> Share


    Proc Natl Acad Sci U S A


  56. Correction for Masliah et al., beta-Amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Proc Natl Acad Sci U S A. 2025;122:e2509530122.
    >> Share

  57. KOH Y, Vazquez-Rosa E, Gao F, Li H, et al
    Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer's disease and traumatic brain injury.
    Proc Natl Acad Sci U S A. 2025;122:e2417224122.
    >> Share

  58. CHEN W, Liu X, Munoz VR, Kahn CR, et al
    Loss of insulin signaling in microglia impairs cellular uptake of Abeta and neuroinflammatory response exacerbating AD-like neuropathology.
    Proc Natl Acad Sci U S A. 2025;122:e2501527122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016